search
Back to results

Legion Primary Safety and Efficacy

Primary Purpose

Osteo Arthritis Knee, Total Knee Replacement

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Total Knee Arthroplasty using Legion Total Knee System
Sponsored by
Smith & Nephew, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Osteo Arthritis Knee focused on measuring Legion Primary, TKA, Osteoarthritis of Knee

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Subjects must meet all of the inclusion criteria:

  • Subject is a candidate for the LEGION™ Primary Knee System according to the instructions for use
  • Subject is of legal age and skeletally mature
  • Subject is willing to sign and date an ethics-approved consent form and participate in the study
  • Subject is willing to be available for ten-year follow-up postoperatively.

Exclusion Criteria: Subjects must not meet any of the exclusion criteria:

  • Subject with immunosuppressive disorders
  • Subject has grossly insufficient femoral or tibial bone stock
  • Subject has an active localized or systemic infection
  • Subject is pregnant
  • Subject psychological or neurological conditions that would impair the subject's ability or willingness to restrict activities or follow medical advice during the course of this study
  • Subject is a prisoner.

Sites / Locations

  • Orthopaedic Associates of Vero Beach
  • Iowa Orthopaedic Center
  • Louisville Bone & Joint Specialist, PSC
  • University Hip and Knee Specialists
  • University Orthopaedic Associates, LLC

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Legion Primary

Arm Description

Legion Primary TKA

Outcomes

Primary Outcome Measures

Implant Survival Rate

Secondary Outcome Measures

Surgical and Device related Adverse Events
All AEs will be collected and reported.
Knee Society Score (KSS) 2011
The new Knee Society Score is composed of five components: Patient Demographics Objective Knee Score - completed by the surgeon. Patient Expectations - completed by the patient Patient Satisfaction Score - completed by the patient Functional Knee Score- completed by the patient. Patient Demographics This section is self-explanatory and includes a detailed modification of the Charnley Functional Classification. This should be included at each evaluation period since the functional classification can change with length of follow-up. Objective Knee Score The new score is not significantly different from the objective knee score of the original KSS. Unlike the old scoring system the new objective score allows for more than 100 points in
Knee Osteoarthritis Outcome Score (KOOS)
Assesses Symptoms and Stiffness, Pain, Function and Daily Living, Function in sports and recreational activity, and Quality of Life. The five patient-relevant subscales of KOOS are scored separately: Pain (nine items) Symptoms (seven items) ADL Function (17 items) Sport and Recreation Function (five items) Quality of Life (four items) A Likert scale is used and all items have five possible answer options scored from 0 (No Problems) to 4 (Extreme Problems) and each of the five scores is calculated as the sum of the items included. Scores are transformed to a 0-100 scale, with zero representing extreme knee problems and 100 representing no knee problems as common in orthopaedic assessment scales and generic measures. Scores between 0 and 100 represent the percentage of total possible score achieved. An aggregate score is not calculated since it is regarded desirable to analyze and interpret the five dimensions separately.
Radiographic Evaluation
Perform weight bearing AP and lateral standard x-rays

Full Information

First Posted
July 18, 2019
Last Updated
May 18, 2022
Sponsor
Smith & Nephew, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT04040985
Brief Title
Legion Primary Safety and Efficacy
Official Title
A Prospective, Multi-Center, Non-Randomized, Safety and Efficacy Clinical Study of the LEGION Primary Knee System for Primary Total Knee Replacement in Subject With Degenerative Knee Disease
Study Type
Interventional

2. Study Status

Record Verification Date
November 2021
Overall Recruitment Status
Terminated
Why Stopped
There is no regulatory or otherwise commitment to continue to follow up to the 10-year time point. The study data had met the primary objectives. After a business review, Smith+Nephew had decided to terminate the study prematurely.
Study Start Date
September 9, 2009 (Actual)
Primary Completion Date
December 17, 2020 (Actual)
Study Completion Date
December 17, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Smith & Nephew, Inc.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study will look at the health results of using the LEGION™ Primary Knee System over a period of ten (10) years. This type of surgery uses an artificial knee made of plastic and metal. This study will enter subjects who suffer from a variety of conditions that have caused at least one of their knees to become nonfunctional. You are being asked to participate in the study because you have significant problems with your knee(s) and your study surgeon has determined that your knee(s) must be surgically replaced to improve your condition. If you decided to participate in this study, you will be one of approximately one hundred thirty-eight (138) subjects in the study.
Detailed Description
This is a prospective, consecutive series, multi-center clinical study of the LEGION™ Total Knee System. The study design was selected to assess the safety and effectiveness profile of the LEGION™ Total Knee System in subjects with degenerative knee disease requiring primary total knee replacement. Subjects meeting the entrance criteria specified in this protocol will be approached to participate in the study and enrolled sequentially. Any consenting subjects meeting the inclusion criteria are not to be excluded unless they do not consent to participate. A nonrandomized, consecutive series of up to 138 subjects will be enrolled at a maximum of 8 research sites, with an expectation of 18 subjects (up to a maximum of 28 subjects) to be enrolled at each site. When 138 subjects are enrolled from all sites, enrollment will be stopped, regardless of the number contributed from each site. Sites will be selected for participation in the study at the discretion of Smith & Nephew. Follow-up clinical assessments will be at Operative/Discharge, 3 months, 1 year, 2 years, 3 years, 5 years, 7 years and 10 years. Each subject will receive a standard radiographic evaluation at discharge that will be used for baseline analysis. Additional radiographic analysis will be performed at Operative/Discharge, 3 months, 1 year, 2 years, 3 years, 5 years, 7 years and 10 years.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteo Arthritis Knee, Total Knee Replacement
Keywords
Legion Primary, TKA, Osteoarthritis of Knee

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
138 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Legion Primary
Arm Type
Other
Arm Description
Legion Primary TKA
Intervention Type
Procedure
Intervention Name(s)
Total Knee Arthroplasty using Legion Total Knee System
Intervention Description
Primary Total Knee Arthroscopy using Legion Total Knee System
Primary Outcome Measure Information:
Title
Implant Survival Rate
Time Frame
Did implant survive with no revision through 10 years
Secondary Outcome Measure Information:
Title
Surgical and Device related Adverse Events
Description
All AEs will be collected and reported.
Time Frame
Through 10 years
Title
Knee Society Score (KSS) 2011
Description
The new Knee Society Score is composed of five components: Patient Demographics Objective Knee Score - completed by the surgeon. Patient Expectations - completed by the patient Patient Satisfaction Score - completed by the patient Functional Knee Score- completed by the patient. Patient Demographics This section is self-explanatory and includes a detailed modification of the Charnley Functional Classification. This should be included at each evaluation period since the functional classification can change with length of follow-up. Objective Knee Score The new score is not significantly different from the objective knee score of the original KSS. Unlike the old scoring system the new objective score allows for more than 100 points in
Time Frame
10 years
Title
Knee Osteoarthritis Outcome Score (KOOS)
Description
Assesses Symptoms and Stiffness, Pain, Function and Daily Living, Function in sports and recreational activity, and Quality of Life. The five patient-relevant subscales of KOOS are scored separately: Pain (nine items) Symptoms (seven items) ADL Function (17 items) Sport and Recreation Function (five items) Quality of Life (four items) A Likert scale is used and all items have five possible answer options scored from 0 (No Problems) to 4 (Extreme Problems) and each of the five scores is calculated as the sum of the items included. Scores are transformed to a 0-100 scale, with zero representing extreme knee problems and 100 representing no knee problems as common in orthopaedic assessment scales and generic measures. Scores between 0 and 100 represent the percentage of total possible score achieved. An aggregate score is not calculated since it is regarded desirable to analyze and interpret the five dimensions separately.
Time Frame
Through 10 years
Title
Radiographic Evaluation
Description
Perform weight bearing AP and lateral standard x-rays
Time Frame
Through 10 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Subjects must meet all of the inclusion criteria: Subject is a candidate for the LEGION™ Primary Knee System according to the instructions for use Subject is of legal age and skeletally mature Subject is willing to sign and date an ethics-approved consent form and participate in the study Subject is willing to be available for ten-year follow-up postoperatively. Exclusion Criteria: Subjects must not meet any of the exclusion criteria: Subject with immunosuppressive disorders Subject has grossly insufficient femoral or tibial bone stock Subject has an active localized or systemic infection Subject is pregnant Subject psychological or neurological conditions that would impair the subject's ability or willingness to restrict activities or follow medical advice during the course of this study Subject is a prisoner.
Facility Information:
Facility Name
Orthopaedic Associates of Vero Beach
City
Vero Beach
State/Province
Florida
ZIP/Postal Code
32960
Country
United States
Facility Name
Iowa Orthopaedic Center
City
Des Moines
State/Province
Iowa
ZIP/Postal Code
50314
Country
United States
Facility Name
Louisville Bone & Joint Specialist, PSC
City
Louisville
State/Province
Kentucky
ZIP/Postal Code
40207
Country
United States
Facility Name
University Hip and Knee Specialists
City
Monroe
State/Province
New Jersey
ZIP/Postal Code
08831
Country
United States
Facility Name
University Orthopaedic Associates, LLC
City
Somerset
State/Province
New Jersey
ZIP/Postal Code
08873
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Legion Primary Safety and Efficacy

We'll reach out to this number within 24 hrs